
179: An Interview With Dr. Daniel Grant, VP and Global Program Head at Novartis
2025-07-02
0:00
13:13
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Daniel Grant, MD, vice president and global program head of neuroscience and gene therapy at Swiss pharma giant Novartis, on emerging therapies for SMA.
Fler avsnitt från "Rare Care Podcast"
Missa inte ett avsnitt av “Rare Care Podcast” och prenumerera på det i GetPodcast-appen.